Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Ying-Ka Ingar Lau, Xing Du, Vinayak Rayannavar, Benjamin Hopkins, Jacquelyn Shaw, Eliana Bessler, Tiffany Thomas, Maira M. Pires, Megan Keniry, Ramon E. Parsons, Serge Cremers, Matthias Szabolcs, Matthew A. Maurer
Published Nov 4, 2014 · Vol. 5, No. 21 · pp. 10503-10517
MarÃa Jesús Ortiz-Ruiz, Stela Ãlvarez-Fernández, Tracy Parrott, Sara Zaknoen, Francis J. Burrows, Alberto Ocaña, Atanasio Pandiella, Azucena EsparÃs-Ogando
Published Nov 4, 2014 · Vol. 5, No. 22 · pp. 11308-11318
Julia Femel, Elisabeth J.M. Huijbers, Falk Saupe, Jessica Cedervall, Lei Zhang, Pernilla Roswall, Erik Larsson, Helena Olofsson, Kristian Pietras, Anna Dimberg, Lars Hellman, Anna-Karin Olsson
Published Oct 24, 2014 · Vol. 5, No. 23 · pp. 12418-12427
Alessandra Bisio, Judit Zámborszky, Sara Zaccara, Mattia Lion, Toma Tebaldi, Vasundhara Sharma, Ivan Raimondi, Federica Alessandrini, Yari Ciribilli, Alberto Inga
Published Oct 21, 2014 · Vol. 5, No. 23 · pp. 12111-12125
Keywords: p53, NFkB, chemotherapy, doxorubicin, TNFï¡ï€» EMT, synergy, breast cancer